warnings
Warnings: For external use only If symptoms persist or worsen, discontinue use and seek medical attention. Avoid contact with eyes. If product gets into eyes, flush with water. Seek medical attention. Not for use on open wounds.
Nyloxin
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Nyloxin
- Generic name
- NAJA NAJA VENOM
- Manufacturer
- Nutra Pharma Corporation
- Product type
- HUMAN OTC DRUG
- SPL set ID
- 289ce7d2-9e9e-4792-92b5-de326007da33
- SPL ID
- d528574b-3205-4631-bd65-beaa5f0ee0ba
- Version
- 5
- Effective date
- 2025-10-14
- Source export date
- 2026-11-06
- Source partition
- 2
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/4dafeb36642dffb72e2138939a956de402f722ea8c14c08cd87068efd3669f01/drug-label-0002-of-0014.json.zip
- Source manifest SHA-256
- 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
- Import run
- 20261108T063105Z
- Imported at
- 2026-11-08 06:50:51
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Nyloxin | openfda.brand_name | |
| generic name | NAJA NAJA VENOM | openfda.generic_name | |
| manufacturer name | Nutra Pharma Corporation | openfda.manufacturer_name | |
| ndc | package | 47219-300-02 | openfda.package_ndc |
| ndc | product | 47219-300 | openfda.product_ndc |
| ndc11 | package | 47219030002 | derived:openfda.package_ndc |
| spl id | d528574b-3205-4631-bd65-beaa5f0ee0ba | id | |
| spl set id | 289ce7d2-9e9e-4792-92b5-de326007da33 | set_id | |
| unii | ZZ4AG7L7VM | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.